European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Gene Ther 27, 537–544 (2020). Science 369, eabc3183 (2020).

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

Pharmaceutical Technology

MAY 9, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate corporate governance. Of the 50 leading companies in the pharmaceutical industry, GSK had the greatest increase in references for corporate governance in Q1 2023, compared with the previous quarter. Buy the report here.

Government 40

Government Pharmaceutical Pharmaceutical manufacturing Manufacturing 40

Pharmaceutical Technology

MAY 9, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Starting at 100 in 2020, an index over 100 is more positive. Buy the report here. The overall index for environmental sustainability in Q1 2023 was 107.

Pharmaceutical 40

Pharmaceutical Pharmaceutical manufacturing Government Manufacturing 40

Impetus Digital

AUGUST 2, 2024

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

pharmaphorum

OCTOBER 26, 2022

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We We start our meetings by bringing to life a patient testimony and asking the team to reflect on how the goal of each meeting ultimately leads back to the needs of patients,” Chiesi says. “If About the author.

Patients 96

Patients Pharma Consulting Transportation 96

European Pharmaceutical Review

JULY 21, 2023

What are the top three supply-related challenges facing pharmaceutical manufacturers? While supply chain challenges became evident during the pandemic, several regions worldwide still face issues leading to product shortages. Additionally, Brexit has introduced uncertainty and disruption, further impacting the sector.

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Transportation Manufacturing 98

Medico Reach

FEBRUARY 8, 2023

The global pharmaceutical manufacturing market stood at USD 405.52 billion in 2020 and will project growth of USD 4.18 billion during 2020-2024. The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. billion in big data analytics.

Pharma 52

Pharma Medicine Marketing Prospecting 52

Clarify Health

OCTOBER 26, 2021

Health inequities in oncology clinical trials In 2020, nearly 5,000 patients participated in clinical trials for 18 newly approved oncology drugs, however, the FDA reported that a disproportionate percent of those participants were White. However, another study found that 0.1% 2] Figure 1.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

PM360

AUGUST 26, 2024

During the period from 2008 through 2020, the number of precision medicines in the US increased from 5 to 285. Cancer detection involves measurement of biomarkers, which leads to the application of targeted therapy (which targets specific cancer cells). Let’s take cancer for example.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharmaceutical Technology

JULY 28, 2022

After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. US Census Bureau statistics for 2020 showed that Charleston’s largest demographic age group is 25 to 34-year-olds. The Charleston region’s labour force is growing three times faster than the national average.

Transportation 52

Transportation Education Marketing Networking 52

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).

Manufacturing 52

Manufacturing Pharmaceutical Pharmaceutical manufacturing Safety 52